2023
Copenhagen, Denmark, 9 December 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today announces that...
8 December, 2023
FluoGuide raises SEK 12 million through exercise of warrants
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...
Copenhagen, Denmark, 29 November 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its...
13 November, 2023
FluoGuide announces FG001 meets primary endpoint in phase llb trial in aggressive brain cancer
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...
6 November, 2023
FluoGuide confirms positive topline results from phase lla trial of FG001 in head & neck cancer at International Academy of Oral Oncology conference
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...
Copenhagen, Denmark – FluoGuide A/S (OMX: FLUO “FluoGuide” or the “Company”), a pioneer in the cutting-edge...
Copenhagen, Denmark, 8 September 2023 – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the...
7 September, 2023
Positive interim data from phase lla trial of FG001 in head & neck cancer presented as a case report at the World Molecular Imaging Congress in Prague
Copenhagen, Denmark, 7 September 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to see...
Copenhagen, Denmark, 30 August 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its...
Calendar &
upcoming reports
29 August 2024
27 November 2024
27 February 2025